E. Alemao - Concepedia

Author

E. Alemao

Bristol-Myers Squibb (United States)ORCID

Also Known As

Alemao, E., C. Ahumada, E Alemao, E. Alemao, E.A. Alemao, Evo A Alemao, Evo Alemao

197

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Brigham and Women's Hospital Albany Medical Center Hospital Center for Rheumatology

About

E. Alemao is an author at Bristol-Myers Squibb (United States) specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	337
2	Public Health	9	9	184
3	Epidemiology	3	3	71
4	Health Sciences	2	2	43
5	Health Information Technology	1	1	17

E. Alemao

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) study Fernando Álvarez Guisasola, Panagiotis Mavros, G Nocea, Diabetes Obesity and Metabolism	2008	91
Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study Éric Van Ganse, Laurent Laforest, E. Alemao, Current Medical Research and Opinion	2005	88
Cost‐effectiveness of sitagliptin‐based treatment regimens in European patients with type 2 diabetes and haemoglobin A1c above target on metformin monotherapy Bernhard Schwarz, Miguel Gouveia, J. Chen, Diabetes Obesity and Metabolism	2008	79
A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma Jean Bousquet, Rami Ben‐Joseph, Mark L. Messonnier, Clinical Therapeutics AsthmaPediatricsPediatric Lung DiseasePulmonary PharmacologyPulmonary Medicine	2002	75
Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty Michael George, Joshua F. Baker, Kevin Winthrop, Annals of Internal Medicine	2019	69
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study Leslie R. Harrold, Heather J. Litman, Seán Connolly, The Journal of Rheumatology	2017	54
Cost, Morbidity, and Control of Asthma in Hungary: The Hunair Study I Herjavecz, György Böszörményi Nagy, K. Gyurkovits, Journal of Asthma	2003	43
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry D. Choquette, Louis Bessette, E. Alemao, Arthritis Research & Therapy	2019	42
Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient‐Reported Outcomes Measurement Information System Short Forms in Systemic Lupus Erythematosus Patricia Katz, Sofia Pedro, E. Alemao, ACR Open Rheumatology	2019	41
Prevalence of Sjögren’s syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry Leslie R. Harrold, Ying Shan, Sabrina Rebello, Clinical Rheumatology	2020	41

Page 1